CATENA, Cristiana
 Distribuzione geografica
Continente #
NA - Nord America 19.633
AS - Asia 8.973
EU - Europa 6.794
SA - Sud America 1.739
AF - Africa 209
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 13
Totale 37.391
Nazione #
US - Stati Uniti d'America 19.366
SG - Singapore 4.308
UA - Ucraina 1.849
CN - Cina 1.815
BR - Brasile 1.370
IT - Italia 1.108
DE - Germania 1.106
HK - Hong Kong 960
FI - Finlandia 801
VN - Vietnam 593
RU - Federazione Russa 484
FR - Francia 381
IE - Irlanda 313
IN - India 245
TR - Turchia 235
SE - Svezia 214
GB - Regno Unito 185
CA - Canada 158
AR - Argentina 150
KR - Corea 137
BD - Bangladesh 134
IQ - Iraq 83
JP - Giappone 67
MX - Messico 67
PK - Pakistan 64
ZA - Sudafrica 59
NL - Olanda 55
BE - Belgio 53
ID - Indonesia 51
CO - Colombia 50
EC - Ecuador 49
AT - Austria 48
PL - Polonia 44
ES - Italia 40
SA - Arabia Saudita 36
UZ - Uzbekistan 36
VE - Venezuela 34
MA - Marocco 30
CZ - Repubblica Ceca 27
CL - Cile 23
JO - Giordania 22
EU - Europa 21
EG - Egitto 20
MY - Malesia 20
PY - Paraguay 19
PE - Perù 18
IR - Iran 17
KE - Kenya 16
LB - Libano 16
TN - Tunisia 16
PH - Filippine 15
UY - Uruguay 14
AE - Emirati Arabi Uniti 13
NP - Nepal 13
AU - Australia 12
DZ - Algeria 11
IL - Israele 11
OM - Oman 11
AZ - Azerbaigian 10
ET - Etiopia 10
RS - Serbia 10
BO - Bolivia 9
CR - Costa Rica 9
KZ - Kazakistan 9
TG - Togo 9
CH - Svizzera 8
XK - ???statistics.table.value.countryCode.XK??? 8
LT - Lituania 7
TW - Taiwan 7
AL - Albania 6
EE - Estonia 6
PS - Palestinian Territory 6
RO - Romania 6
SN - Senegal 6
AM - Armenia 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
KH - Cambogia 5
PA - Panama 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
BW - Botswana 4
DK - Danimarca 4
GR - Grecia 4
KG - Kirghizistan 4
RE - Reunion 4
CI - Costa d'Avorio 3
CY - Cipro 3
GY - Guiana 3
HR - Croazia 3
HU - Ungheria 3
MU - Mauritius 3
NO - Norvegia 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BT - Bhutan 2
Totale 37.334
Città #
Woodbridge 2.091
Singapore 1.862
Fairfield 1.829
Ashburn 1.501
Ann Arbor 1.475
Jacksonville 1.306
Houston 1.124
Chandler 975
Hong Kong 954
Beijing 849
Dearborn 788
Wilmington 783
Seattle 724
Cambridge 648
San Jose 522
Boardman 431
Princeton 336
Dublin 311
Lauterbourg 309
Munich 270
Los Angeles 227
Helsinki 205
Udine 183
Buffalo 179
Izmir 163
Hefei 150
Ho Chi Minh City 147
Dallas 139
San Diego 128
Hanoi 125
Seoul 124
Council Bluffs 109
São Paulo 108
New York 103
Redondo Beach 96
Milan 89
The Dalles 88
Ottawa 79
Des Moines 78
Santa Clara 73
Ogden 71
Orem 66
Norwalk 65
Tokyo 58
Dong Ket 53
Frankfurt am Main 53
Pittsburgh 53
Nanjing 51
Mumbai 50
Kunming 49
Rome 48
Redmond 47
Rio de Janeiro 45
San Mateo 45
Warsaw 43
Guangzhou 42
Brussels 40
Nuremberg 39
Baghdad 34
Brooklyn 34
Atlanta 33
Belo Horizonte 33
Johannesburg 33
Chennai 31
London 31
Manchester 31
Tashkent 31
Amsterdam 30
Phoenix 30
Stockholm 30
Brasília 29
Montreal 27
Shanghai 27
Chicago 26
Vienna 26
Denver 25
Grafing 25
Boston 24
Da Nang 24
Falls Church 24
Trieste 24
Dhaka 23
Haiphong 23
Brno 22
Turku 22
Ankara 21
San Francisco 21
Düsseldorf 20
Jinan 20
Mexico City 20
New Delhi 20
Toronto 20
Washington 19
Amman 18
Goiânia 18
Lahore 18
Porto Alegre 18
Paris 17
Hyderabad 16
Poplar 16
Totale 23.633
Nome #
Alcohol Intake and Arterial Hypertension: Retelling of a Multifaceted Story 271
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 267
Abnormalities of glucose metabolism and cardiovascular events in patients with hypertensive nephrosclerosis and mild renal failure 246
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 237
Abnormalities of insulin receptors in spontaneously hypertensive rats 204
Aldosterone and the heart: from basic research to clinical evidence 203
Aldosterone and Left Ventricular Remodeling 196
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 195
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 182
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 181
Aldosterone and the heart: still an unresolved issue? 179
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 179
Abnormalities of glucose metabolism in patients with early renal failure 177
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 176
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 176
Aldosterone, Organ Damage, and Dietary Salt 173
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 172
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 169
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 168
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 167
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 166
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 165
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 165
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 163
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 160
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 160
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 159
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 159
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 158
Diabetes, diabetic complications, and blood pressure targets 158
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 158
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 158
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 156
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 156
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 155
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 154
The emergent cardiovascular risk factors and organ damage in arterial hypertension 153
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 153
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 152
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 152
Treatment of primary aldosteronism and organ protection 152
Prohypertensive effect of insulin: possible role of the sympathetic system 151
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 150
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 149
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 149
Cardiovascular outcomes in patients with primary aldosteronism after treatment 149
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 149
Salt, hypertension, and cardiovascular disease 148
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 146
Benzodiazepines: an old class of new antihypertensive drugs? 145
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 145
Spontaneous restoration of sinus rhythm after cardiac surgery 144
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 143
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 143
Renal hyperfiltration and increased prevalence of cystic disease in patients with primary aldosteronism 143
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 143
Renal function in primary aldosteronism 142
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 142
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 142
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 141
The SPARTACUS Trial: Controversies and Unresolved Issues 141
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 141
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 140
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 140
Kidney in primary aldosteronism: a key determinant of treatment outcome 138
Potassium-sparing diuretics in hypertension 137
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 136
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 136
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 135
Abnormalities of carbohydrate metabolism and cardiovascular disease in patients with early renal failure 134
Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension 134
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial 134
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 134
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 134
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 133
Glucose metabolism in early renal failure 133
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 133
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 132
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study 132
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 131
Benign familial macrocytosis 131
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 131
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 129
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: The EPATH trial 128
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 127
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 127
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 126
ACIDI GRASSI POLIINSATURI OMEGA-3 E FATTORI DI RISCHIO CARDIOVASCOLARE 126
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort 126
Effects of zofenopril, carvedilol, and lacidipine on alcohol-induced responses in cultured human endothelial cells 125
Hypertension and abnormalities of carbohydrate metabolism: possible role of sympathetic nervous system 125
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 125
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 125
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 125
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 125
Ambulatory blood pressure and left ventricular geometry in patients with myotonic dystrophy 124
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 124
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 124
Endothelial function in patients with non-alcoholic fatty liver disease 123
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 123
Totale 15.221
Categoria #
all - tutte 143.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021747 0 0 0 0 0 0 0 0 0 131 432 184
2021/20222.474 103 289 98 182 69 88 145 160 26 414 474 426
2022/20232.604 371 118 36 299 234 781 11 166 377 49 88 74
2023/2024870 141 72 55 42 167 93 26 21 105 34 9 105
2024/20255.930 141 420 174 184 116 320 396 383 640 431 1.073 1.652
2025/20269.989 783 1.138 906 1.015 1.668 901 1.490 377 907 804 0 0
Totale 38.269